Innovative Cannabis Genetics Phylos specializes in producing industry-first Production-Ready Seed hybrids that offer high stability, potency, and yield, making them an attractive partner for cultivators seeking reliable, premium genetics.

Strategic Industry Partnerships Recent collaborations with ILGM and Organigram demonstrate Phylos’s focus on expanding its product offerings through exclusive and hybrid seed development, providing sales opportunities with large-scale cannabis producers.

Emerging Consumer Technologies Phylos has launched innovative genotype and sex testing solutions along with extensive genetic databases, presenting opportunities to supply genetic testing tools and data-driven cultivation solutions to dispensaries and growers.

Focus on Research and Efficacy With ongoing clinical studies on THCV in partnership with prominent organizations, Phylos positions itself as a science-driven company, opening doors to collaborate in research, ingredient development, and targeted consumer health products.

Market Expansion Potential Recent product launches and strategic partnerships indicate a growing market presence and potential for sales expansion into different segments of the cannabis and biotech industry, especially among large-scale cultivators and biotech firms.